FTC Battles Monopolies in Pharma

This chapter examines the FTC's actions against monopolistic practices in the pharmaceutical industry, particularly targeting inhaler manufacturers. It also discusses the challenges faced by the DOJ in regulating major mergers, highlighting the complexities of antitrust enforcement and its impact on competition in healthcare.